Haemonetics HAE Japan — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's japan — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's japan — net revenues?
- Haemonetics (HAE) reported japan — net revenues of $18.4M in Q1 2026.
- How has Haemonetics's japan — net revenues changed year-over-year?
- Haemonetics's japan — net revenues increased by 14.3% year-over-year, from $16.11M to $18.4M.
- What is the long-term trend for Haemonetics's japan — net revenues?
- Over 4 years (2022 to 2026), Haemonetics's japan — net revenues has grown at a -2.5% compound annual growth rate (CAGR), from $75.56M to $68.2M.
- What does japan — net revenues mean?
- This metric measures the total sales generated from products and services provided by the company within the Japanese market, net of returns, allowances, and discounts. It serves as a primary indicator of the company's commercial success, market penetration, and demand for its medical solutions in this specific geography. Tracking this revenue stream allows stakeholders to evaluate regional growth trends and the effectiveness of local sales strategies.